|
Volumn 1, Issue 1, 2005, Pages 73-78
|
Restenosis after percutaneous angioplasty: the role of vascular inflammation.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE PHASE PROTEIN;
ANTIINFLAMMATORY AGENT;
BIOLOGICAL MARKER;
HEME OXYGENASE 1;
HMOX1 PROTEIN, HUMAN;
IL6 PROTEIN, HUMAN;
INTERLEUKIN 6;
UNCLASSIFIED DRUG;
ARTERITIS;
ATHEROSCLEROSIS;
BLOOD;
GENETIC POLYMORPHISM;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
METABOLISM;
PATHOPHYSIOLOGY;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PERIPHERAL VASCULAR DISEASE;
PREDICTION AND FORECASTING;
RECURRENT DISEASE;
REVIEW;
RISK FACTOR;
STENOSIS, OCCLUSION AND OBSTRUCTION;
VASCULAR PATENCY;
ACUTE-PHASE PROTEINS;
ANGIOPLASTY, BALLOON;
ANTI-INFLAMMATORY AGENTS;
ARTERITIS;
ATHEROSCLEROSIS;
BIOLOGICAL MARKERS;
CONSTRICTION, PATHOLOGIC;
GENETIC PREDISPOSITION TO DISEASE;
HEME OXYGENASE-1;
HUMANS;
INTERLEUKIN-6;
PERIPHERAL VASCULAR DISEASES;
POLYMORPHISM, GENETIC;
PREDICTIVE VALUE OF TESTS;
RECURRENCE;
RISK FACTORS;
VASCULAR PATENCY;
|
EID: 33947492116
PISSN: 11766344
EISSN: None
Source Type: Journal
DOI: 10.2147/vhrm.1.1.73.58932 Document Type: Review |
Times cited : (102)
|
References (79)
|